You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc

XNAS: TELO

Download real time

4.35 0.23 (5.58%)

53.67% Fall from 52W High

109.7K XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
5S
6W
3O
1T
129.5

Market Cap

Below industry Median
-7.8

PE TTM

Negative PE TTM
0.3

PEG TTM

PEG TTM is less than 1
201.4

Price to Book

High in industry
-0.5

Beta 1Year

Very Low volatility


Insider Trading disclosures for Telomir Pharmaceuticals Inc

The latest disclosure was made by Erez Aminov in Telomir Pharmaceuticals Inc where a trade of 200 Common Stock done at an average price of $6.0 was reported to US exchanges on Dec. 31, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Erez Aminov Director, CEO and Chairman 31 Dec 2024 200 29,600 - 6.0 1,202 Common Stock
Erez Aminov Director, CEO and Chairman 31 Dec 2024 200 29,600 - 6.2 1,240 Common Stock
Michael Jerman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 25,000 25,000 - - Incentive Stock Options (right to buy)
Matthew Pratt Whalen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 25,000 25,000 - - Incentive Stock Options (right to buy)
Michelle Yanez Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 200,000 200,000 - - Incentive Stock Options (right to buy)
Matthew Paul Del Giudice Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 25,000 25,000 - - Incentive Stock Options (right to buy)
Erez Aminov Director, CEO & Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 1,960,170 1,960,170 - - Incentive Stock Options (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters